FDA recommends against use of fluroquinolones for 1) acute bacterial sinusitis, 2) acute exacerbations of chronic bronchitis.and 3) uncomplicated urinary tract infection because of increasing concerns about adverse effects.
The warning emphasized the adverse effects of hypoglycemia and various psychiatric symptoms.
For possible mechanisms regarding fluroquinolone related hypoglycemia see this detailed review.
No comments:
Post a Comment